Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd

₹ 1,272 1.05%
22 Nov - close price
About

Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Key Points

Business
Company provides healthcare services and operates a chain of multi specialty, tertiary, and primary healthcare facilities. As of Q3 FY24, it has a network of 18 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with ~5,640 operational beds and a capacity of ~6,040 beds[1]

  • Market Cap 25,999 Cr.
  • Current Price 1,272
  • High / Low 1,445 / 1,080
  • Stock P/E 60.6
  • Book Value 95.3
  • Dividend Yield 0.31 %
  • ROCE 22.7 %
  • ROE 25.5 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 53.0% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.9%

Cons

  • Stock is trading at 13.4 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
622 634 620 695 747 738 785 797 852 771 846 872 934
553 551 544 595 621 606 665 659 688 633 690 715 752
Operating Profit 69 83 77 101 125 131 119 138 164 138 156 157 183
OPM % 11% 13% 12% 14% 17% 18% 15% 17% 19% 18% 18% 18% 20%
12 6 83 5 27 9 60 9 14 11 89 14 13
Interest 10 9 10 9 9 12 14 13 13 13 14 20 20
Depreciation 30 30 30 31 31 38 39 38 39 41 44 39 42
Profit before tax 42 50 119 65 112 90 127 96 126 95 187 110 134
Tax % 35% 35% 35% 35% 35% 35% 28% 18% 13% 17% 15% 22% 21%
27 32 78 43 73 58 92 79 109 79 158 86 106
EPS in Rs 1.32 1.59 3.80 2.08 3.56 2.86 4.50 3.86 5.33 3.85 7.74 4.23 5.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
825 1,076 1,308 1,470 1,646 1,848 2,077 2,239 1,655 2,412 2,965 3,266 3,423
738 960 1,182 1,295 1,427 1,664 1,881 1,971 1,676 2,146 2,471 2,656 2,789
Operating Profit 87 115 126 175 219 184 196 268 -21 266 494 609 633
OPM % 11% 11% 10% 12% 13% 10% 9% 12% -1% 11% 17% 19% 19%
2 25 10 2 14 16 17 19 71 104 95 120 127
Interest 17 29 38 23 17 26 43 55 48 45 55 65 69
Depreciation 44 55 64 67 68 78 91 128 123 119 139 161 166
Profit before tax 28 56 34 86 147 95 79 104 -121 206 395 503 526
Tax % 35% 36% 38% 34% 35% 39% 37% 35% -35% 35% 33% 16%
18 36 21 57 95 58 50 68 -79 134 266 425 429
EPS in Rs 566.99 1,107.25 1.05 2.77 4.65 2.86 2.45 3.31 -3.85 6.54 13.00 20.77 20.98
Dividend Payout % 0% 0% 0% 0% 0% 0% 41% 30% 0% 15% 19% 19%
Compounded Sales Growth
10 Years: 12%
5 Years: 9%
3 Years: 25%
TTM: 8%
Compounded Profit Growth
10 Years: 32%
5 Years: 53%
3 Years: 98%
TTM: 27%
Stock Price CAGR
10 Years: %
5 Years: 34%
3 Years: 30%
1 Year: 3%
Return on Equity
10 Years: 10%
5 Years: 13%
3 Years: 20%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.33 0.33 200 204 204 204 204 204 204 204 204 204 204
Reserves 533 569 595 753 854 916 963 962 885 1,021 1,264 1,636 1,744
238 321 289 152 120 491 499 607 551 533 644 1,011 957
156 237 216 274 309 383 410 449 462 528 664 645 805
Total Liabilities 927 1,128 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 3,710
503 626 651 650 682 973 949 1,159 1,070 1,094 1,358 1,480 1,914
CWIP 44 12 9 13 52 30 56 3 5 23 32 34 37
Investments 31 51 241 334 354 561 597 619 645 661 678 1,021 941
348 438 399 386 399 431 475 441 382 507 709 962 818
Total Assets 927 1,128 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 3,710

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
45 164 61 177 218 196 208 286 123 246 516 542
-122 -172 -192 -130 -162 -446 -137 -129 -12 -117 -621 -761
87 5 127 -2 -32 226 -11 -170 -114 -57 65 237
Net Cash Flow 9 -3 -4 46 25 -24 61 -12 -3 72 -40 19

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 40 45 40 34 31 37 28 24 34 26 22 21
Inventory Days 58 63 55 46 42 41 36 24 19 18 17 28
Days Payable 121 206 136 142 161 179 165 171 237 177 211 192
Cash Conversion Cycle -23 -98 -41 -62 -88 -102 -101 -124 -184 -133 -172 -143
Working Capital Days 11 -12 6 3 -1 -5 -15 -23 -34 -23 -27 -23
ROCE % 6% 9% 7% 11% 15% 9% 8% 9% -4% 15% 23% 23%

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85%
10.80% 10.64% 10.03% 9.55% 10.24% 10.36% 11.10% 11.59% 11.51% 10.91% 10.01% 9.69%
18.96% 18.34% 17.85% 16.62% 14.58% 14.14% 11.95% 10.89% 10.23% 9.51% 8.22% 7.90%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.00%
5.69% 6.47% 7.59% 9.28% 10.70% 11.01% 12.45% 13.05% 13.78% 15.12% 17.29% 17.94%
0.70% 0.70% 0.69% 0.69% 0.63% 0.63% 0.63% 0.62% 0.62% 0.62% 0.62% 0.62%
No. of Shareholders 43,80752,74765,17368,13073,15775,37086,6311,02,9941,20,5061,38,0521,60,6861,78,356

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls